Concise Summary for Procurement: Pegylated Mechano-Growth Factor

Section 1: Product Identification and Core Information

This document provides a concise summary for the procurement of Pegylated Mechano-Growth Factor, Catalog ID: PEGMGF-RES-001.

Product Overview

Detail

Description

Catalog ID

PEGMGF-RES-001

Compound Name

Pegylated Mechano-Growth Factor

Chemical Description

A synthetic, pegylated form of the MGF splice variant of IGF-1.

Modification

Features a polyethylene glycol chain for extended half-life and stability.

Intended Use

Research and development purposes only. Not for human or animal therapeutic use.

Physical and Chemical Specifications

Parameter

Specification

Form

White Lyophilized Powder

Purity

>98%

Storage (Lyophilized)

Store at -20°C

Shelf Life

[To be confirmed upon delivery]

Section 2: Compound Function and Research Applications

Pegylated Mechano-Growth Factor (PEGMGF-RES-001) is a critical research tool due to its enhanced stability and targeted biological activity.

Biological Context

The parent molecule, Mechano-Growth Factor (MGF), is a splice variant of Insulin-like Growth Factor-1 (IGF-1) produced locally in tissues, particularly muscle, following mechanical stress or damage.

Key Research Areas

PEGMGF-RES-001 is widely used in research settings to study the following biological processes:

• Muscle Hypertrophy: Investigating pathways leading to muscle growth and repair.
• Cardiac Repair: Studying potential roles in regenerating heart tissue after injury.
• Stem Cell Activation: Research into the mobilization and differentiation of local stem cell populations.

The pegylation process ensures the compound remains stable in research media for extended periods, allowing for longer-duration in vitro and in vivo studies.

Section 3: Handling, Storage, and Safety Requirements

The buyer assumes all responsibility for safe handling, proper storage, and disposal of this bioactive peptide.

Storage and Preparation

The compound is shipped as a white lyophilized powder and must be handled carefully to maintain integrity.

Condition

Requirement

Primary Storage

-20°C (Lyophilized state)

Handling Environment

Clean, dry environment, minimizing exposure to moisture.

Reconstitution Solvent

[Specific solvent to be determined by research protocol]

Working Solution Storage

[Guidance for short-term storage of reconstituted solution]

Safety Protocols (Mandatory)

PEGMGF-RES-001 is a bioactive peptide. Standard laboratory safety practices are required.

1. Wear appropriate Personal Protective Equipment (PPE), including lab coats, gloves, and eye protection.
2. Work under a fume hood or in a biological safety cabinet if preparing concentrated solutions.
3. Avoid inhalation of the powder and contact with skin or eyes.
4. Dispose of all waste (powder and solutions) according to institutional and local regulations for biological and chemical waste.

Section 4: Procurement Documentation Checklist

The following documents must be secured by the procurement team for a compliant purchase.

Document

Purpose

Status

Material Safety Data Sheet (MSDS)

Essential safety and chemical information

File

Certificate of Analysis (CoA)

Batch-specific purity and quality verification

File

Product Specification Sheet

Detailed technical and chemical data

File

Regulatory Compliance Statement

Verification of research-grade status

[Complete]

Section 5: Quality Assurance and Supplier Vetting

Due to the sensitivity of research materials, rigorous quality assurance is mandatory.

Supplier Verification Steps

• Certification: Verify the supplier’s ISO or equivalent quality management certification.
• Cold Chain Logistics: Confirm the supplier's capacity to maintain the -20°C cold chain during transport to the facility located at Place.
• Lot Consistency: Inquire about the manufacturer’s procedures for ensuring lot-to-lot consistency.

Section 6: Detailed Compound Structure and Stability

Pegylation Rationale

The polyethylene glycol (PEG) chain modification serves several critical purposes for research material:

1. Extended Half-Life: Reduces degradation by proteases, crucial for in vivo longevity.
2. Increased Stability: Enhances solubility and resistance to aggregation.
3. Reduced Immunogenicity: Minimizes the potential for an immune response in animal models.

Purity Assurance

The stated purity of $>98%$ is verified using High-Performance Liquid Chromatography (HPLC). The procurement team must confirm the method and acceptance criteria listed on the Certificate of Analysis (CoA).

Section 7: Packaging and Shipping Requirements

The vendor must adhere to strict packaging protocols to preserve the integrity of the lyophilized peptide.

Packaging Details

• Vial Type: Glass, sealed under inert gas or vacuum.
• Secondary Containment: Insulated container with temperature monitoring.
• Shipping Medium: Dry ice, sufficient to maintain -20°C or below until expected delivery on Date.

Receiving Protocol

The designated recipient, Person, must inspect the shipment immediately upon arrival to:

1. Confirm the internal temperature logging data.
2. Verify the seal integrity of the primary product vial.
3. Transfer the product directly to the specified -20°C storage unit.

Section 8: Financial and Order Specifications

The following table summarizes current purchasing requirements for this product.

Item

Requirement

Notes

Current Quantity Needed

[Placeholder for specific quantity]

Usually measured in milligrams (mg)

Target Price (per mg)

[Placeholder for price]

Obtain quotes from multiple vendors.

Lead Time (Expected)

[Placeholder for duration]

Must be aligned with the start of project Calendar event.

Vendor Contract ID

[Placeholder for Vendor Contract ID]

Reference for accounting purposes.

Section 9: Potential Research Timeline Integration

This procurement is essential for the commencement of the "Muscle Regeneration Study," scheduled to begin on Date.

Project Milestones and PEGMGF-RES-001 Use

Milestone

Target Date

Requirement

Procurement Finalized

Date

Purchase Order issued.

Product Receipt

Date

Must be in facility storage.

In Vitro Assays Start

Date

Initial reconstitution and testing.

In Vivo Dosing Preparation

Date

Required for animal model introduction.

Section 10: Summary and Approval

PEGMGF-RES-001 is a high-purity, research-grade peptide requiring strict adherence to cold-chain logistics and safety protocols. This summary is intended to facilitate an efficient and compliant procurement process.

Approval Signatures

The procurement of Catalog ID: PEGMGF-RES-001 is recommended based on the specifications detailed in this document.

Role

Name

Signature Date

Principal Investigator

Person

Date

Procurement Officer

Person

Date